No Picture
News

Drug development 101: Gilead goes back to school with new program to attract Black and Hispanic students to pharma

Drug developers at Gilead Sciences are moonlighting as college professors these days. However, it’s not a side hustle for extra income, but a new program to help draw Black and Hispanic students to the industry. Chemists, manufacturing experts, biologi… […]

No Picture
News

MarketingRx roundup: AbbVie’s Humira TV turns focus to HS skin condition; Sanofi amps parenting policy

After years as the top spending pharma TV advertiser, AbbVie’s Humira brand finally downshifted earlier this year, ceding much of its marketing budget to up-and-coming sibling meds Skyrizi and Rinvoq. However, now Humira is back on TV with ads for anot… […]

No Picture
News

FFF Enterprises Launches on MediLedger to Improve Pricing Alignment in Pharma Supply Chain, through Blockchain

SAN FRANCISCO: SAN FRANCISCO, Nov. 30, 2021 /PRNewswire/ — Today, FFF Enterprises Inc. (FFF), the industry-leading supplier of critical-care biopharmaceuticals, vaccines, and plasma products, and Chronicled, the technology company behind the blockchai… […]

No Picture
News

Tarsier’s CEO and Founder, Dr. Daphne Haim Langford, wins the 2021 EU Prize for Women Innovators

TEL AVIV, Israel: TEL AVIV, Israel, Nov. 30, 2021 /PRNewswire/ — The EU Prize for Women Innovators is awarded to the most talented women entrepreneurs from across the EU and associated countries (including Israel), celebrating the women entrepreneurs … […]

No Picture
News

Sciwind gets licensing deal with Sanofi for metabolic disease candidates; ImmunityBio and EnGeneIC reach deal for nano cell tech

Sciwind Biosciences announced last night that it signed an expansive license agreement with Sanofi to develop and commercialize Sanofi’s long-lasting glucose-dependent insulinotropic polypeptide (GIP) receptor agonists. According to Sciwind, the lead c… […]

No Picture
News

ImmunoGen touts a PhIII comeback in ovarian cancer, eyeing a 2022 accelerated approval

When ImmunoGen’s lead antibody-drug conjugate flunked a Phase III study in ovarian cancer a couple years ago, the company clung to hope that it would perform better in a subgroup of patients with high folate receptor alpha (FRα) expression. On Tuesday,… […]

No Picture
News

Ex-Apple / Tesla Leaders Raise $1,000,000 in 1 Hour From Retail Investors, On Track to Release World’s First Artificial Human Arm

SAN FRANCISCO–(BUSINESS WIRE)–Ex-Apple / Tesla Leaders Raise $1,000,000 in 1 Hour From Retail Investors, On Track to Release World’s First Artificial Human Arm. […]